Birdwatch Note
2023-11-30 17:33:38 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
For context, Nachtrab has consistently tried to harm Bik's reputation apparently because 1) Bik noted serious scientific fraud in the papers supporting Cassava Sciences' main product, an Alzheimer's drug: https://x.com/MicrobiomDigest/status/1730042874618949822?s=20 https://x.com/MattNachtrab/status/1717848994179658076?s=20 https://twitter.com/search?q=from%3A%40MattNachtrab%20Bik&src=typed_query And 2) Nachtrab owns >1 mill Cassava shares: https://archive.ph/xS3Ne (view page source:) https://www.tortoisemedia.com/audio/the-alzheimers-casino/
Written by 3E213470F2899085F0CCF0D79EC51D296B8895711A85DA165B3C57051F5C9CA7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730188697826459669
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1730278930475516037
- noteId - 1730278930475516037
- participantId -
- noteAuthorParticipantId - 3E213470F2899085F0CCF0D79EC51D296B8895711A85DA165B3C57051F5C9CA7 Participant Details
- createdAtMillis - 1701365618714
- tweetId - 1730188697826459669
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- For context, Nachtrab has consistently tried to harm Bik's reputation apparently because 1) Bik noted serious scientific fraud in the papers supporting Cassava Sciences' main product, an Alzheimer's drug: https://x.com/MicrobiomDigest/status/1730042874618949822?s=20 https://x.com/MattNachtrab/status/1717848994179658076?s=20 https://twitter.com/search?q=from%3A%40MattNachtrab%20Bik&src=typed_query And 2) Nachtrab owns >1 mill Cassava shares: https://archive.ph/xS3Ne (view page source:) https://www.tortoisemedia.com/audio/the-alzheimers-casino/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-30 17:33:38 UTC (1701365618714) |
2023-11-30 22:11:49 UTC (1701382309603) |
CURRENTLY_RATED_HELPFUL | 2023-12-01 03:12:04 UTC (1701400324779) |
CURRENTLY_RATED_HELPFUL | 2023-11-30 22:11:49 UTC (1701382309603) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-11-30 17:04:24 -0600 | Rating Details | |
| 2023-11-30 16:51:12 -0600 | Rating Details | |
| 2023-11-30 15:57:37 -0600 | Rating Details | |
| 2023-11-30 15:43:01 -0600 | Rating Details | |
| 2023-11-30 15:25:05 -0600 | Rating Details | |
| 2023-11-30 14:17:19 -0600 | Rating Details | |
| 2023-11-30 13:56:50 -0600 | Rating Details | |
| 2023-11-30 13:53:36 -0600 | Rating Details | |
| 2023-11-30 13:47:50 -0600 | Rating Details | |
| 2023-11-30 13:43:41 -0600 | Rating Details | |
| 2023-11-30 13:11:39 -0600 | Rating Details | |
| 2023-11-30 13:01:38 -0600 | Rating Details | |
| 2023-12-01 19:11:14 -0600 | Rating Details | |
| 2023-12-01 17:03:39 -0600 | Rating Details | |
| 2023-12-01 15:32:54 -0600 | Rating Details | |
| 2023-12-01 13:09:26 -0600 | Rating Details | |
| 2023-12-01 12:06:40 -0600 | Rating Details | |
| 2023-12-01 08:13:09 -0600 | Rating Details | |
| 2023-12-01 03:44:08 -0600 | Rating Details | |
| 2023-12-01 03:42:16 -0600 | Rating Details | |
| 2023-12-01 03:12:57 -0600 | Rating Details | |
| 2023-12-01 03:10:49 -0600 | Rating Details | |
| 2023-12-01 02:59:39 -0600 | Rating Details | |
| 2023-12-01 00:08:18 -0600 | Rating Details | |
| 2023-11-30 21:49:11 -0600 | Rating Details | |
| 2023-11-30 17:11:35 -0600 | Rating Details | |
| 2023-11-30 16:40:54 -0600 | Rating Details | |
| 2023-11-30 16:33:49 -0600 | Rating Details | |
| 2023-11-30 15:29:06 -0600 | Rating Details | |
| 2023-11-30 15:16:05 -0600 | Rating Details | |
| 2023-11-30 14:45:06 -0600 | Rating Details | |
| 2023-11-30 14:21:42 -0600 | Rating Details | |
| 2023-11-30 13:49:10 -0600 | Rating Details | |
| 2023-11-30 13:49:03 -0600 | Rating Details | |
| 2023-11-30 13:46:30 -0600 | Rating Details | |
| 2023-11-30 13:42:49 -0600 | Rating Details | |
| 2023-11-30 13:37:05 -0600 | Rating Details | |
| 2023-11-30 13:24:07 -0600 | Rating Details | |
| 2023-11-30 13:12:02 -0600 | Rating Details | |
| 2023-11-30 12:39:29 -0600 | Rating Details | |
| 2023-11-30 12:17:50 -0600 | Rating Details | |
| 2023-11-30 11:56:16 -0600 | Rating Details | |
| 2023-11-30 11:47:01 -0600 | Rating Details | |
| 2023-12-02 14:58:36 -0600 | Rating Details | |
| 2023-12-02 12:50:49 -0600 | Rating Details | |
| 2023-12-02 12:17:21 -0600 | Rating Details | |
| 2023-12-02 11:55:15 -0600 | Rating Details | |
| 2023-12-02 11:54:41 -0600 | Rating Details | |
| 2023-12-01 10:29:31 -0600 | Rating Details | |
| 2023-12-01 09:45:36 -0600 | Rating Details | |
| 2023-12-01 09:01:45 -0600 | Rating Details | |
| 2023-12-01 08:39:14 -0600 | Rating Details | |
| 2023-12-01 07:50:05 -0600 | Rating Details | |
| 2023-12-01 07:29:51 -0600 | Rating Details | |
| 2023-12-01 06:20:45 -0600 | Rating Details | |
| 2023-12-01 06:01:23 -0600 | Rating Details | |
| 2023-12-01 05:05:36 -0600 | Rating Details | |
| 2023-12-01 04:57:32 -0600 | Rating Details | |
| 2023-12-01 00:15:14 -0600 | Rating Details | |
| 2023-11-30 22:44:05 -0600 | Rating Details | |
| 2023-11-30 21:07:28 -0600 | Rating Details | |
| 2023-11-30 20:32:45 -0600 | Rating Details | |
| 2023-11-30 20:32:25 -0600 | Rating Details | |
| 2023-11-30 20:18:51 -0600 | Rating Details | |
| 2023-11-30 18:36:03 -0600 | Rating Details | |
| 2023-12-03 16:03:21 -0600 | Rating Details | |
| 2023-12-03 16:32:39 -0600 | Rating Details | |
| 2023-12-03 16:09:46 -0600 | Rating Details | |
| 2023-12-03 16:08:59 -0600 | Rating Details | |
| 2023-12-03 11:57:32 -0600 | Rating Details | |
| 2023-12-03 01:23:36 -0600 | Rating Details | |
| 2023-12-02 16:38:08 -0600 | Rating Details | |
| 2023-12-02 14:48:56 -0600 | Rating Details | |
| 2023-12-02 13:05:22 -0600 | Rating Details | |
| 2023-12-02 11:48:54 -0600 | Rating Details | |
| 2023-12-02 11:46:26 -0600 | Rating Details | |
| 2023-12-02 07:23:25 -0600 | Rating Details | |
| 2023-12-02 06:30:08 -0600 | Rating Details | |
| 2023-12-05 15:21:45 -0600 | Rating Details | |
| 2023-12-04 23:32:42 -0600 | Rating Details | |
| 2023-12-06 01:47:37 -0600 | Rating Details | |
| 2023-12-01 13:10:46 -0600 | Rating Details | |
| 2023-12-01 07:39:36 -0600 | Rating Details | |
| 2023-11-30 20:22:54 -0600 | Rating Details |